Neocell Corporation – Trademark Portfolio
Entity Type: 03
Neocell Corporation holds 25 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 23 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include NEOCELL, GLOW MATRIX, and BEAUTY INFUSION. The owner is based in Irvine, CA.
17500 Gillette Avenue
Irvine, CA 92614
Showing of trademarks Trademarks
Trademark Classifications
Neocell Corporation's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Neocell Corporation have?
Neocell Corporation has 25 U.S. trademarks filed with the USPTO. Of these, 4 registered, 14 abandoned, 7 cancelled.
What trademark classes does Neocell Corporation file in?
Neocell Corporation files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Neocell Corporation's most well-known trademarks?
Neocell Corporation's registered trademark portfolio includes well-known marks such as NEOCELL, GLOW MATRIX, and BEAUTY INFUSION. These are among 4 currently registered trademarks in the portfolio.
What is Neocell Corporation's trademark registration success rate?
Neocell Corporation has a 16% trademark registration rate, with 4 out of 25 resolved applications resulting in successful registration. Currently, 0 applications are pending review.